MTL Cannabis Corp. (CSE: MTLC) has received its final approval to list its common shares on the Canadian Securities Exchange under the symbol “MTLC”
The company announced Thursday that its shares will start trading at the opening of the market on August 21.
“Successfully completing a listing on the CSE is a significant milestone and the last step in the business combination between Canada House Cannabis Group Inc. and Montréal Medical Cannabis Inc,” MTL Cannabis CEO Michael Perron said.
“Our team has put forward an incredible effort to get us to this point and we are incredibly excited to continue to integrate the businesses and position the company as a top performer in the Canadian cannabis industry.”
On July 31, MTL Cannabis –previously known as Canada House Cannabis Group Inc.– announced the completion of its Reverse Takeover transaction (RTO) following a favorable vote by over 99 per cent of the shares represented at its annual general and special meeting.
Read more: Valens to manufacture pre-rolls and vapes for MTL Cannabis
Read more: MTL Cannabis RTO of Canada House to close early 2022
MTL Cannabis boasts a 57,000 sq. ft. indoor cultivation facility in Pointe-Claire, Québec.
Additionally, it oversees Abba Medix Corp., a distinguished medical cannabis marketplace in Pickering, Ontario; IsoCanMed Inc., another licensed producer in Louiseville, Québec with a 64,000 sq. ft. production space; and Canada House Clinics Inc., which operates clinics nationwide, offering specialized cannabinoid therapy services.
Prioritizing craft quality, MTL Cannabis has introduced a range of products, including dried flower, pre-rolls, and hash, under various brands.
